Afinitor Approved for Rare Pancreatic Cancer (HealthDay)

Admin

Administrator
Staff member
HealthDay - FRIDAY, May 6 (HealthDay News) -- U.S. Food and Drug Administration approval of Afinitor (everolimus) has been expanded to include people with progressive neuroendocrine tumors of the pancreas (PNET) that have spread to other parts of the body or cannot be removed by surgery, the agency said Friday.

More...
 
Top